Literature DB >> 20186579

Revision laparoscopic gastric bypass: an effective approach following failure of primary bariatric procedures.

Numan Hamza1, Ammar Darwish, Mohannad B Ammori, Muhammad Hasan Abbas, Basil J Ammori.   

Abstract

BACKGROUND: The laparoscopic approach plays an important role in the primary surgical management of morbid obesity. This study evaluated the potential role of the laparoscopic approach to revision Roux-en-Y gastric bypass (LRYGB) in the management of selected patients who fail to lose adequate weight or regain weight after primary bariatric surgery.
METHODS: Revision LRYGB was carried out to remedy early or delayed failure of primary bariatric procedures. Patients who underwent laparoscopic revision surgery to re-establish a functioning gastric band were not included in this report. The results are presented as mean (SD).
RESULTS: Between April 2002 and March 2009, 21 patients underwent 21 laparoscopic revision procedures. The initial bariatric operations were laparoscopic gastric band (n = 10), open vertical banded gastroplasty (n = 6), open Magenstrasse and Mill (n = 2), open gastric bypass with pouch dilatation (n = 2), and open gastric band (n = 1). All revision procedures were completed laparoscopically and included conversion to LRYGB (n = 19), and others (n = 2). The postoperative hospital stay was 2.0 (1.3) days. The anastomotic leak, morbidity, and mortality rates were 0%, 4.8%, and 0% respectively. At a follow-up of 12.9 (7.9) months, the prerevision body mass index has decreased significantly from 43.9 (7.4) to 32.7 (6.6) kg/m(2) (p < 0.001) with a percentage excess weight loss of 61.1 (21.2).
CONCLUSIONS: The laparoscopic approach to revision Roux-en-Y gastric bypass is safe and effective even in patients with previous open bariatric surgery and is associated with rapid recovery and short hospital stay.

Entities:  

Mesh:

Year:  2010        PMID: 20186579     DOI: 10.1007/s11695-010-0104-4

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  42 in total

1.  Revision of failed gastric bypass to distal Roux-en-Y gastric bypass: a review of 65 cases.

Authors:  M A Fobi; H Lee; D Igwe; B Felahy; E James; M Stanczyk; J Tambi; P Eyong
Journal:  Obes Surg       Date:  2001-04       Impact factor: 4.129

2.  Duodenal switch is a safe operation for patients who have failed other bariatric operations.

Authors:  Ara Keshishian; Karin Zahriya; Teny Hartoonian; Chris Ayagian
Journal:  Obes Surg       Date:  2004-10       Impact factor: 4.129

Review 3.  Revisional bariatric surgery for inadequate weight loss.

Authors:  Andrew A Gumbs; Alfons Pomp; Michel Gagner
Journal:  Obes Surg       Date:  2007-09       Impact factor: 4.129

4.  Predictors of success after laparoscopic gastric bypass: a multivariate analysis of socioeconomic factors.

Authors:  R Lutfi; A Torquati; N Sekhar; W O Richards
Journal:  Surg Endosc       Date:  2006-05-02       Impact factor: 4.584

5.  Meta-analysis: surgical treatment of obesity.

Authors:  Melinda A Maggard; Lisa R Shugarman; Marika Suttorp; Margaret Maglione; Harvey J Sugerman; Harvey J Sugarman; Edward H Livingston; Ninh T Nguyen; Zhaoping Li; Walter A Mojica; Lara Hilton; Shannon Rhodes; Sally C Morton; Paul G Shekelle
Journal:  Ann Intern Med       Date:  2005-04-05       Impact factor: 25.391

6.  Laparoscopic revision from LAP-BAND to gastric bypass.

Authors:  Hadar Spivak; Oscar R Beltran; Plamen Slavchev; Erik B Wilson
Journal:  Surg Endosc       Date:  2007-03-14       Impact factor: 4.584

7.  Outcomes with the adjustable gastric band.

Authors:  Ramsey M Dallal; Linda Bailey
Journal:  Surgery       Date:  2008-01-22       Impact factor: 3.982

8.  Factors associated with weight loss after gastric bypass.

Authors:  Guilherme M Campos; Charlotte Rabl; Kathleen Mulligan; Andrew Posselt; Stanley J Rogers; Antonio C Westphalen; Feng Lin; Eric Vittinghoff
Journal:  Arch Surg       Date:  2008-09

9.  Laparoscopic vs open gastric bypass in the management of morbid obesity: a 7-year retrospective study of 1,364 patients from a single center.

Authors:  Emmanuel Atta Agaba; Hazem Shamseddeen; Charmaine Victoria Gentles; Venketesh Sasthakonar; Larry Gellman; Dominick Gadaleta
Journal:  Obes Surg       Date:  2008-04-26       Impact factor: 4.129

10.  Variations of weight loss following gastric bypass and gastric band.

Authors:  Nancy Puzziferri; Paul A Nakonezny; Edward H Livingston; Thomas J Carmody; David A Provost; A John Rush
Journal:  Ann Surg       Date:  2008-08       Impact factor: 12.969

View more
  6 in total

1.  Conversion from band to bypass in two steps reduces the risk for anastomotic strictures.

Authors:  Yves Van Nieuwenhove; Wim Ceelen; Katrien Van Renterghem; Dirk Van de Putte; Tom Henckens; Piet Pattyn
Journal:  Obes Surg       Date:  2011-04       Impact factor: 4.129

2.  The safety of laparoscopic hand-sutured gastrojejunostomy in gastric bypass for the treatment of morbid obesity.

Authors:  Babur Ahmed; Basil J Ammori
Journal:  Obes Surg       Date:  2013-09       Impact factor: 4.129

Review 3.  Laparoscopic Roux-en-Y gastric bypass or laparoscopic sleeve gastrectomy as revisional procedure after adjustable gastric band--a systematic review.

Authors:  Usha K Coblijn; Caroline J Verveld; Bart A van Wagensveld; Sjoerd M Lagarde
Journal:  Obes Surg       Date:  2013-11       Impact factor: 4.129

Review 4.  Gastrogastric fistulae following gastric bypass surgery-clinical recognition and treatment.

Authors:  Eric M Pauli; Hiba Beshir; Abraham Mathew
Journal:  Curr Gastroenterol Rep       Date:  2014-09

5.  Endoscopic management of gastrogastric fistulae does not increase complications at bariatric revision surgery.

Authors:  Michael S Flicker; David B Lautz; Christopher C Thompson
Journal:  J Gastrointest Surg       Date:  2011-04-09       Impact factor: 3.452

6.  Robotically assisted revision of bariatric surgeries is safe and effective to achieve further weight loss.

Authors:  Brad Snyder; Todd Wilson; Vicky Woodruff; Erik Wilson
Journal:  World J Surg       Date:  2013-11       Impact factor: 3.352

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.